Vanderbilt’s center for innovation The Wond’ry will be absorbed into the university’s school of engineering this fall, ...

Fueled by a sustained boom in sales of its diabetes and obesity products, Eli Lilly will become the world’s top-seller of prescription drugs by 2030 and will hold the top rung by a wide margin. | ...

INDIANAPOLIS — The new board members for the Indiana Economic Development Corporation held their first meeting since Gov.

Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge announces a $300 million funding round.

Eli Lilly said on Saturday its experimental pill orforglipron helped diabetics lose weight and lower their blood sugar, and the company aims to announce in the third quarter trial results for the ...

Eli Lilly’s first quarter saw rapid revenue growth, but the market responded negatively due to profit shortfalls and emerging ...

The Eli Lilly and Company-Bond has a maturity date of 2/12/2055 and offers a coupon of 5.5000%. The payment of the coupon will take place 2,0 times per biannual on the 12.08.. At the current price ...

A GLP-1 in pill form from Eli Lilly shows promising results for weight loss and Type 2 diabetes treatment in a trial. FDA approval is expected in 2026.

Eli Lilly is looking to approach regulators for approval of its once-weekly insulin for type 2 diabetes (T2D) after it proved non-inferior to daily dosing. The QWINT-1 (NCT05662332), QWINT-3 ...

Gov. Mike Braun this week announced nine appointments to the Indiana Economic Development Corporation Board of Directors.